InnoCare Pharma Ltd. (INCPF)
1.55
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.735B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -52.45% |
| Valuation | |
| PE Ratio | 20.86 |
| PE Ratio (Forward) | |
| PS Ratio | 6.883 |
| Price to Book Value | 2.419 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.2911 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 58.33% |
Profile
| InnoCare Pharma Ltd. is a clinical-stage biopharmaceutical company. It engages in discovering, developing and commercializing drugs for the treatment of cancer and autoimmune diseases. The company was founded by Jisong Cui and Yigong Shi on November 3, 2015 and is headquartered in Beijing, China. |
| URL | http://www.innocarepharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Beijing |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Mar. 25, 2027 (est.) |
| Last Earnings Release | Aug. 24, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| InnoCare Pharma Ltd. is a clinical-stage biopharmaceutical company. It engages in discovering, developing and commercializing drugs for the treatment of cancer and autoimmune diseases. The company was founded by Jisong Cui and Yigong Shi on November 3, 2015 and is headquartered in Beijing, China. |
| URL | http://www.innocarepharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Beijing |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Mar. 25, 2027 (est.) |
| Last Earnings Release | Aug. 24, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |